UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

The Skin Microbiome & Cosmeceuticals Congress presentation slides

Following the Skin Microbiome & Cosmeceuticals Congress: Europe, we have made the following presentation slides from Richard Andrews, Ingmar Claes, Marie Drago & Maya Ivanjesku available.

Read More

Assessment of the European Court of Justice ruling on gene editing for crop improvement

Anyone involved in the field of agriculture and biotechnology would have been unable to ignore the ECJ ruling on case C-528/16 in July 2018. The ruling confirmed that all plants obtained by any form of mutagenesis are GMOs as defined by Directive (EC) no. 2001/18 and rejected an annulment of mutagenesis exemption (Annex IB of Directive 2001/18. With significant ramifications across the industry, the ECJ stance on gene edited crops and GMOs was a major focus of the 7th Plant Genomics & Gene Editing Congress: Europe.

Read More

Strategic screening enables effective biomarker discovery

During my eight years at the Max Planck Institute for Molecular Genetics in Berlin, I led a protein technologies group. We developed a protein expression library, and then high-content protein arrays. In total, we made arrays with 10,000 different human proteins.

Read More

Flow Cytometry: A powerful tool in drug discovery

Flow cytometry is a powerful tool in drug discovery because it provides a way to understand the drug’s mechanism of action. In order to stratify a better target for patients, you often need to know where the drug is working, and what kind of pathway it is operating along.

Read More

A novel fungal endophyte confers fitness benefits to crops

Researchers at the Polytechnic University of Madrid (UPM) in Spain, in collaboration with scientists with PlantResponse Biotech, S.L., are conducting research on a novel fungal endophyte that confers crop fitness benefits, particularly in alkaline soils.

Read More

Why do biomarkers fail?

When conducting an experiment to identify biomarkers, it is crucial to design the experiment properly. 80-90% of all biomarker populations for the last 20 years have not and cannot be reproduced, and the main reason that biomarkers fail is that these experiments are not designed properly. In this post, I will outline two ways in which experiments are poorly designed, and then outline the technological and methodological solution in a later blog.

Read More

Putting the power of proteomics in the hands of Flow Cytometry

The combination of simplicity and power is turning flow cytometry into the highest throughput protein analysis method yet developed.

Large-scale protein analysis, or proteomics, is still a relatively small discipline where the research front is driven by a few labs with unrestricted access to mass spectrometry (MS). MS is equivalent to a mainframe computer: very big, very sophisticated, and only a few people have the skills to use them.

Read More

A 14 colour antibody panel: developing a tool and demonstrating a process

One of the frustrations I have with Flow Cytometry is when companies present their amazing new findings at conferences, and it’s quite often about TMB cells. In my case, I work on these cells perhaps 20% of the time. The rest of the time I work on cells from other parts of the human body – bone marrow, lung, bronchoalveolar lavage, spleen – and in diverse animals such as mice, rats, and even sparrow, chicken, and mosquito.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive